Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Fiona Y. Glassman, Robert Dingman, Helena C. Yau & Sathy V. Balu-Iyer. (2020) Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles. Immunological Investigations 49:7, pages 858-874.
Read now
Read now
Runhui Wu & Koon Hung Luke. (2017) The benefit of low dose prophylaxis in the treatment of hemophilia: a focus on China. Expert Review of Hematology 10:11, pages 995-1004.
Read now
Read now
E. Carlos Rodriguez-Merchan & Hortensia De la Corte-Rodriguez. (2017) Side effects and potential risk factors of botulinum toxin type A intramuscular injections in knee flexion contractures of hemophiliacs. Expert Review of Hematology 10:7, pages 587-594.
Read now
Read now
H. De la Corte-Rodriguez & E. C. Rodriguez-Merchan. (2016) The ICF (International Classification of Functioning, Disability and Health) developed by the WHO for measuring function in hemophilia. Expert Review of Hematology 9:7, pages 661-668.
Read now
Read now
E. Carlos Rodriguez-Merchan. (2016) Patient dissatisfaction after total knee arthroplasty for hemophilic arthropathy and osteoarthritis (non-hemophilia patients). Expert Review of Hematology 9:1, pages 59-68.
Read now
Read now
Articles from other publishers (19)
Isaiah A. Reeves, Rebecca S. Blue, Serena Auñon-Chancellor, Michael F. Harrison, Ronak Shah & William E. Powers. (2023) Tolerance of Centrifuge-Simulated Commercial Spaceflight in a Subject with Hemophilia A. Aerospace Medicine and Human Performance 94:6, pages 470-474.
Crossref
Crossref
Matteo Borro, Riccardo Tassara, Luca Paris, Nathan Artom, Marcello Brignone, Lara Rebella & Rodolfo Tassara. (2023) Acquired Hemophilia A Treated with Recombinant Porcine Factor VIII: Case Report and Literature Review on Its Efficacy. Hematology Reports 15:1, pages 17-22.
Crossref
Crossref
Timothy Dreyer, Mittal Shah, Carl Doyle, Kevin Greenslade, Mark Penney, Paul Creeke, Apoorva Kotian, Hua Zhu Ke, Vinny Naidoo & Gill Holdsworth. (2021) Recombinant sclerostin inhibits bone formation in vitro and in a mouse model of sclerosteosis. Journal of Orthopaedic Translation 29, pages 134-142.
Crossref
Crossref
Marguerite Lockhart, Brigitte Tardy‐Poncet, Aurélie Montmartin, Pauline Noyel, Sandrine Thouvenin & Claire Berger. (2021) Surgery with emicizumab prophylaxis for two paediatric patients with severe haemophilia A with inhibitors. Pediatric Blood & Cancer 68:7.
Crossref
Crossref
Tahereh Zadeh Mehrizi & Kamran Mousavi Hosseini. (2021) An overview on the investigation of nanomaterials' effect on plasma components: immunoglobulins and coagulation factor VIII, 2010–2020 review. Nanoscale Advances 3:13, pages 3730-3745.
Crossref
Crossref
Esteban Cruz & Veysel Kayser. 2020. Biologics, Biosimilars, and Biobetters. Biologics, Biosimilars, and Biobetters
47
69
.
Jee Won Ahn, Eun Sun Chang, You Jin Jung, So Ra Kim, Baik L. Seong & Suk Hoon Ha. (2020) Characterization of the von Willebrand factor/factor VIII complex produced by a novel purification process. Archives of Pharmacal Research 43:7, pages 714-723.
Crossref
Crossref
Navid Shomali, Tohid Gharibi, Ghasem Vahedi, Rebar N. Mohammed, Hamed Mohammadi, Sevda Salimifard & Faroogh Marofi. (2019) Mesenchymal stem cells as carrier of the therapeutic agent in the gene therapy of blood disorders. Journal of Cellular Physiology 235:5, pages 4120-4134.
Crossref
Crossref
Kewa Gao, Priyadarsini Kumar, Elizabeth Cortez-Toledo, Dake Hao, Lizette Reynaga, Melanie Rose, Chuwang Wang, Diana Farmer, Jan Nolta, Jianda Zhou, Ping Zhou & Aijun Wang. (2019) Potential long-term treatment of hemophilia A by neonatal co-transplantation of cord blood-derived endothelial colony-forming cells and placental mesenchymal stromal cells. Stem Cell Research & Therapy 10:1.
Crossref
Crossref
Gary E. Gilbert. (2019) The evolving understanding of factor VIII binding sites and implications for the treatment of hemophilia A. Blood Reviews 33, pages 1-5.
Crossref
Crossref
R. Hartmann, T. Feenstra, L. Valentino, M. Dockal & F. Scheiflinger. (2018) In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents. Journal of Thrombosis and Haemostasis 16:8, pages 1580-1591.
Crossref
Crossref
Wei Sun, Wei Zheng & Anton Simeonov. (2017) Drug discovery and development for rare genetic disorders. American Journal of Medical Genetics Part A 173:9, pages 2307-2322.
Crossref
Crossref
Christoph Kannicht, Mario Kröning, Barbara Solecka-Witulska, Guido Kohla & Julia Rosenlöcher. (2017) Comparative N-Glycosylation Analysis of the Fc Portions of a Chimeric Human Coagulation Factor VIII and Immunoglobulin G1. Bioengineering 4:2, pages 44.
Crossref
Crossref
S. Garger, J. Severs, L. Regan, A. Hesslein, J. Ignowski, P. Wu, E. Long, S. Gupta, S. Liu & W. Wang. (2017) BAY 81-8973, a full-length recombinant factor VIII: manufacturing processes and product characteristics. Haemophilia 23:2, pages e67-e78.
Crossref
Crossref
Steven W. Pipe. (2016) New therapies for hemophilia. Hematology 2016:1, pages 650-656.
Crossref
Crossref
Q Wang, B Dong, J Firrman, W Wu, S Roberts, A R Moore, L S Liu, M P S Chin, Y Diao, J Kost & W Xiao. (2016) Evaluation of the biological differences of canine and human factor VIII in gene delivery: implications in human hemophilia treatment. Gene Therapy 23:7, pages 597-605.
Crossref
Crossref
Aleksander Skotnicki, Toshko J. Lissitchkov, Vasily Mamonov, Evgeny Buevich, Kazimierz Kuliczkowski, Stefcho Goranov, Janusz Kłoczko, Anna Klukowska, Svetlana Stankovic, Liana Gercheva, Tatiana Chernova, Andrzej Hellmann, Anna Dmoszyńska, Krystyna Zawilska, Alex Veldman, Christine Joch & Wilfried Seifert. (2016) Efficacy, safety and pharmacokinetic profiles of a plasma-derived VWF/FVIII concentrate (VONCENTO®) in subjects with haemophilia A (SWIFT-HA study). Thrombosis Research 137, pages 119-125.
Crossref
Crossref
E.M. Sokal, C. Lombard & G. Mazza. (2015) Mesenchymal stem cell treatment for hemophilia: a review of current knowledge. Journal of Thrombosis and Haemostasis 13, pages S161-S166.
Crossref
Crossref
James H. Kurasawa, Svetlana A. Shestopal, Samuel A. Woodle, Mikhail V. Ovanesov, Timothy K. Lee & Andrey G. Sarafanov. (2014) Cluster III of Low-Density Lipoprotein Receptor-Related Protein 1 Binds Activated Blood Coagulation Factor VIII. Biochemistry 54:2, pages 481-489.
Crossref
Crossref